Outpatient Management of Patients With COVID-19: Multicenter Prospective Validation of the Hospitalization or Outpatient Management of Patients With SARS-CoV-2 Infection Rule to Discharge Patients Safely.

Douillet, Delphine;Penaloza-Baeza, Andrea;Mahieu, Rafaël;Morin, François;Hospitalization or Outpatient Management of Patients With SARS-CoV-2 Infection Study Group;et.al.
(2021) Chest : the cardiopulmonary and critical care journal — Vol. 160, n° 4, p. 1222-1231 (2021)

Files

OutpatientmanagementofpatientswithCOVID-19.pdf
  • Open Access
  • Adobe PDF
  • 469.8 KB
Download

Details

Authors
  • Douillet, DelphineUCLouvain
    Author
  • Penaloza-Baeza, AndreaUCLouvain
    Author
  • Mahieu, Rafaël
    Author
  • Morin, François
    Author
  • Savary, DominiqueUCLouvain
    Author
  • Hospitalization or Outpatient Management of Patients With SARS-CoV-2 Infection Study Group
    Collaborator
Show more
Abstract
(en) BACKGROUND: The Hospitalization or Outpatient Management of Patients With SARS-CoV-2 Infection (HOME-CoV) rule is a checklist of eligibility criteria for home treatment of patients with COVID-19, defined using a Delphi method. RESEARCH QUESTION: Is the HOME-CoV rule reliable for identifying a subgroup of COVID-19 patients with a low risk of adverse outcomes who can be treated at home safely? STUDY DESIGN AND METHODS: We aimed to validate the HOME-CoV rule in a prospective, multicenter study before and after trial of patients with probable or confirmed COVID-19 who sought treatment at the ED of 34 hospitals. The main outcome was an adverse evolution, that is, invasive ventilation or death, occurring within the 7 days after patient admission. The performance of the rule was assessed by the false-negative rate. The impact of the rule implementation was assessed by the absolute differences in the rate of patients who required invasive ventilation or who died and in the rate of patients treated at home, between an observational and an interventional period after implementation of the HOME-CoV rule, with propensity score adjustment. RESULTS: Among 3,000 prospectively enrolled patients, 1,239 (41.3%) demonstrated a negative HOME-CoV rule finding. The false-negative rate of the HOME-CoV rule was 4 in 1,239 (0.32%; 95% CI, 0.13%-0.84%), and its area under the receiver operating characteristic curve was 80.9 (95% CI, 76.5-85.2). On the adjusted populations, 25 of 1,274 patients (1.95%) experienced an adverse evolution during the observational period vs 12 of 1,274 patients (0.95%) during the interventional period: -1.00 (95% CI, -1.86 to -0.15). During the observational period, 858 patients (67.35%) were treated at home vs 871 patients (68.37%) during the interventional period: -1.02 (95% CI, -4.46 to 2.26). INTERPRETATION: A large proportion of patients treated in the ED with probable or confirmed COVID-19 have a negative HOME-CoV rule finding and can be treated safely at home with a very low risk of complications. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT04338841; URL: www.clinicaltrials.gov.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Douillet, D., Penaloza-Baeza, A., Mahieu, R., Morin, F., Chauvin, A., Gennai, S., Schotte, T., Montassier, E., Thiebaud, P.-C., Ghuysen François, A., Dall’acqua, D., Benhammouda, K., Bissokele, P., Violeau, M., Joly, L.-M., Andrianjafy, H., Soulie, C., Savary, D., Riou, J., & Roy, P.-M. (2021). Outpatient Management of Patients With COVID-19: Multicenter Prospective Validation of the Hospitalization or Outpatient Management of Patients With SARS-CoV-2 Infection Rule to Discharge Patients Safely. Chest : the cardiopulmonary and critical care journal, 160(4), 1222-1231. https://doi.org/10.1016/j.chest.2021.05.008 (Original work published 2021)